Bruno Lewin
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 22
- COVID-19 Clinical Research Studies 7
- Health 23
- Vaccine Coverage and Hesitancy 23
- Co-authors
- Eric Weintraub (18 shared papers)Nicola P. Klein (16 shared papers)Jason M. Glanz (15 shared papers)Simon J. Hambidge (11 shared papers)Allison L. Naleway (10 shared papers)Ousseny Zerbo (8 shared papers)Elyse O. Kharbanda (8 shared papers)Joshua T.B. Williams (9 shared papers)
- Journals
- Vaccine (11 papers)Nature Communications (5 papers)PEDIATRICS (4 papers)Open Forum Infectious Diseases (3 papers)JAMA Network Open (2 papers)
- Partner nations
- United StatesUnited KingdomThailand
In The Last Decade
Bruno Lewin
55 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 672
- Health 233
- Neurology 172
- Virology 50
- Modeling and Simulation 47
Countries citing papers authored by Bruno Lewin
This map shows the geographic impact of Bruno Lewin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Lewin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Lewin more than expected).
Fields of papers citing papers by Bruno Lewin
This network shows the impact of papers produced by Bruno Lewin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Lewin. The network helps show where Bruno Lewin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Lewin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Surveillance for Adverse Events After COVID-19 mRNA Vaccination Hit paper breakdown → | 2021 | 434 |
| 2 | 2021 | 87 | |
| 3 | Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system Hit paper breakdown → | 2023 | 74 |
| 4 | 2019 | 66 | |
| 5 | 2022 | 40 | |
| 6 | 2022 | 37 | |
| 7 | 2022 | 35 | |
| 8 | 2018 | 32 | |
| 9 | 2022 | 32 | |
| 10 | 1968 | 28 | |
| 11 | 2023 | 24 | |
| 12 | 2020 | 23 | |
| 13 | 2015 | 22 | |
| 14 | 2021 | 16 | |
| 15 | 2018 | 15 | |
| 16 | 2018 | 15 | |
| 17 | 2023 | 14 | |
| 18 | 2024 | 14 | |
| 19 | 2020 | 11 | |
| 20 | 2024 | 8 |
About Bruno Lewin
Bruno Lewin is a scholar working on Infectious Diseases, Health, Epidemiology, Language and Linguistics and Surgery, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (23 papers), SARS-CoV-2 and COVID-19 Research (22 papers), Influenza Virus Research Studies (13 papers), COVID-19 Clinical Research Studies (7 papers), Linguistic Education and Pedagogy (6 papers), Viral Infections and Immunology Research (5 papers), Pneumonia and Respiratory Infections (5 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Infectious Diseases (672 citations), Health (233 citations), Neurology (172 citations), Virology (50 citations) and Modeling and Simulation (47 citations). Bruno Lewin has collaborated with scholars based in United States, United Kingdom and Thailand. Frequent co-authors include Eric Weintraub, Nicola P. Klein, Jason M. Glanz, Simon J. Hambidge, Allison L. Naleway, Ousseny Zerbo, Elyse O. Kharbanda, Joshua T.B. Williams, Jennifer C. Nelson and Tom T. Shimabukuro. Their work appears in journals such as Vaccine, Nature Communications, PEDIATRICS, Open Forum Infectious Diseases and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.